Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
HIV Resistance and Sequencing Related Publications Q1 2012 Journal Title Author Link AIDS Research and Therapy HIV-1 Subtype distribution in Morocco based on national sentinel surveillance data 20042005 M. Akrim, et al. Abstract Antimicrobial Agents and Chemotherapy N. C. T. Schopman, Abstract Directed HIV-1 Evolution of Protease Inhibitor Resistance by et al. Second-Generation Short Hairpin RNAs G. J. Henderson, et Interplay between Single Resistance-Associated Mutations al. in the HIV-1 Protease and Viral Infectivity, Protease Activity, and Inhibitor Sensitivity Abstract In Vitro Resistance Profile of the Candidate HIV-1 Microbicide Drug Dapivirine S. M. Schader, et al. Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase (RT) Mutations on Nucleoside RT Inhibitor Susceptibility G. L. Melikian, et al. Abstract Differential Use of CCR5 by HIV1 Clinical Isolates Resistant to Small Molecule CCR5 Antagonists T. J. Henrich, et al. Abstract Abstract Relative Impact of HIV-1 Reverse G. L. Melikian, et al. Abstract Transcriptase Mutations on Nucleoside RT Inhibitor Susceptibility: A Standardized Comparison The role of natural polymorphisms in HIV-1 CRF02_AG protease on protease inhibitor hypersusceptibility A. F. A. Santos, et al. Abstract Broad Phenotypic CrossResistance to Elvitegravir in HIVInfected Patients Failing on Raltegravir-Containing Regimens C. Garrido, et al. Abstract Journal of virological methods Evaluation of genotypic prediction of HIV-1 tropism using population sequencing of replicates J. L. DE PAULA FERREIRA, et al. Abstract Clinical Infectious Diseases Incidence of HIV-1 Drug Resistance Among Antiretroviral Treatment–Naive Individuals Starting Modern Therapy Combinations V. von Wyl, et al. Abstract A comparison of 3 regimens to prevent nevirapine resistance mutations in hiv-infected pregnant women receiving a single intrapartum dose of nevirapine R. B. Van Dyke, et al. Abstract HIV-1 Subtype and Virological Response to Antiretroviral Therapy: Acquired Drug Resistance E. A. Soares, et al. Abstract Dried Blood Spot Specimens Are a Suitable Alternative Sample Type for HIV-1 Viral Load Measurement and Drug Resistance Genotyping in Patients Receiving First-Line Antiretroviral Therapy E. K. Rottinghaus, et al. Abstract Viremia and HIV-1 Drug Resistance Mutations Among Patients Receiving Second-Line Highly Active Antiretroviral Therapy in Chennai, Southern India S. Saravanan, et al. Abstract Increasingly Successful Highly Active Antiretroviral Therapy Delays the Emergence of New HLA Class I–Associated Escape Mutations in HIV-1 D. J. H. F. Knapp, et al. Abstract Patterns of HIV-1 Drug Resistance After First-Line R. L. Hamers, et al. Abstract Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies HIV-1 Drug Resistance Resulting from Antiretroviral Therapy Far Exceeds that from Pre-Exposure Prophylaxis U. M. Parikh, et al. Abstract Intervirology Epidemiology of Transmitted Drug Resistance in Chronically HIV-Infected Patients in Germany: The RESINA Study 2001–2009 M. Oette, et al. Abstract PloS one J. H. Brehm, et al. Zidovudine (AZT) Monotherapy Selects for the A360V Mutation in the Connection Domain of HIV-1 Reverse Transcriptase Abstract HIV-1 Subtype D Infections among Caucasians from Northwestern Poland— Phylogenetic and Clinical Analysis M. Parczewski, et al. Abstract Emergence of Minor DrugResistant HIV-1 Variants after Triple Antiretroviral Prophylaxis for Prevention of Vertical HIV-1 Transmission A. Hauser, et al. Abstract Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa J. H. Levison, et al. Abstract Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden 2003–2010 A. Karlsson, et al. Abstract The Origin and Evolutionary History of HIV-1 Subtype C in Senegal M. Jung, et al. Abstract BF Integrase Genes of HIV-1 Circulating in São Paulo, Brazil, with a Recurrent Recombination A. Iamarino, et al. Abstract Region M. Bronze, et al. HIV-1 Phenotypic Reverse Transcriptase Inhibitor Drug Resistance Test Interpretation Is Not Dependent on the Subtype of the Virus Backbone Abstract PLoS Pathogens M. R. Henn, et al. Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection Abstract AIDS reviews Temporal Changes in the Epidemiology of Transmission of Drug-Resistant HIV-1 across the World D. Frentz, et al. A. K. Nyamache Extent of drug resistance mutations among HIV-1 positive drug-naive patients in Kenya abstract International HIV pediatrics workshop in 2009 Cape Town South Africa on July 17-18th 2009. International journal of reviews in antiviral therapy Vol 6 A-05 pg 105 (2009) Journal of Antimicrobial Chemotherapy Abstract Abstract A non-infectious cell-based phenotypic assay for the assessment of HIV-1 susceptibility to protease inhibitors M. J. Buzon, et al. Abstract Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor T. J. Barber, et al. Abstract Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan C. C. Lai, et al. Abstract High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype M. Franzetti, et al. Abstract Journal of Clinical Microbiology The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors J. L. MartinezCajas, et al. Abstract HIV-1 protease mutation 82M contributes to phenotypic resistance to protease inhibitors in subtype G A. C. Palma, et al. Abstract Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy S. Baroncelli, et al. Abstract Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 ‘non-B’-infected patients C. Charpentier, et al. Abstract Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen J. Burgos, et al. Abstract N. Mantovani, et al. Analyses of transmitted resistance and selective pressure in HIV-1 naïve patients to Raltegravir and failure HAART in São Paulo, Brazil Abstract C. K. Woods, et al. Abstract Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool Journal of the International Association of Physicians in AIDS Care (JIAPAC) Adherence and Preexisting Major E. M. Gardner, et al. Protease Inhibitor Resistance Mutations are Associated with Virologic Failure of a Dual-Class Antiretroviral Regimen with Inhibitors of HIV-1 Viral Protease and Integrase Journal of Infectious Diseases Molecular Determinants of HIV-2 R5–X4 Tropism in the V3 Loop: Development of a New Genotypic Tool B. Visseaux, et al. Abstract Abstract AIDS JAIDS - Journal of Acquired Immune Deficiency Syndromes Transmission of the X4 Phenotype of HIV-1: Is There Evidence Against the “Random Transmission” Hypothesis? C. Hedskog, et al. Abstract Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing D. Armenia, et al. Abstract Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in sub-Saharan Africa K. C. E. Sigaloff, et al. Abstract Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine M. A. Micek, et al. Abstract Blood mitochondrial DNA mutations in HIV-infected women and their infants exposed to highly active antiretroviral therapy during pregnancy M. H. J. Jitratkosol, et al. Abstract Tracing the origin and history of HIV-1 subtype B'epidemic in China by near full-length genome analyses Z. Li, et al. Abstract Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure J. Z. Li, et al. Abstract Discrepancies Between WHO 2009 and IAS-USA 2009 Lists for Determining the Rate of Transmitted HIV-1 Drug Resistance: A Prospective Study S. Sungkanuparph, et al. Abstract Genotypic and phenotypic characterization of HIV-1 isolates obtained from patients on L. Rimsky, et al. Abstract rilpivirine therapy experiencing virologic failure in the phase 3 ECHO and THRIVE studies: 48week analysis Journal of Virology The HIV-1 reverse transcriptase M184I mutation enhances the E138K-associated resistance to rilpivirine and decreases viral fitness R. Kulkarni, et al. Reverse Transcriptase Substitution at Codons 208 and 228 Among TreatmentExperienced HIV-1 Subtype-C– Infected Indian Patients Is Strongly Associated With Thymidine Analogue Mutations S. Saravanan, et al. Abstract AF4 HIV Drug Resistance in Nigeria, a Cost-Effective New Methodology P. Kanki, et al. Abstract Does Genetic Diversity of HIV-1 Non-B Subtypes Differentially Impact Disease Progression in Treatment-Naive HIV-1–Infected Individuals? A Systematic Review of Evidence: 1996–2010 N. Pant Pai, et al. Abstract Molecular Epidemiology of HIV-1 Infection in Taiwan from 2005 to 2008: Further Spread of CRF07_BC and Emergence of CRF07_BC/Subtype B Dual Infection Y. J. Chen, et al. Abstract Does Genetic Diversity of HIV-1 Non-B Subtypes Differentially Impact Disease Progression in Treatment-Naive HIV-1 Infected Individuals?: A Systematic Review of Evidence: 1996-2010 N. P. Pai, et al. Abstract Rapid Expansion of a HIV-1 Subtype F Cluster of Recent Origin Among Men Who Have Sex With Men in Galicia, Spain M. Thomson, et al. Abstract Mutations of Gln64 in the HIV-1 gp41 N-Terminal Heptad Repeat X. Yu, et al. Abstract Abstract Render Viruses Resistant to Peptide HIV Fusion Inhibitors Targeting the gp41 Pocket P. K. Quashie, et Characterization of the R263K Mutation in HIV-1 Integrase That al. Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir Abstract Vicriviroc Resistance Decay and Relative Replicative Fitness in HIV-1 Clinical Isolates Under Sequential Drug Selection Pressures A. M. N. Tsibris, et al. Abstract Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity M. A. Brockman, et al. Abstract Molecular biology and evolution Inconsistencies in estimating the age of HIV-1 subtypes due to heterotachy J. O. Wertheim, et al. Abstract AIDS Research and Human Retroviruses HIV Type 1 Viral Encephalitis After Development of Viral Resistance to Plasma Suppressive Antiretroviral Therapy M. del Palacio Tamarit, et al. Abstract C. Charpentier, et Virological Response and Resistance Profiles After 18 to 30 al. Months of First-or Second-/ThirdLine Antiretroviral Treatment: A Cross-Sectional Evaluation in HIV Type 1-Infected Children Living in the Central African Republic Abstract Monitoring of HIV Type 1 DNA Load and Drug Resistance in Peripheral Blood Mononuclear Cells During Suppressive Antiretroviral Therapy Does Not Predict Virologic Failure I. A. Beck, et al. Abstract HIV Type 1 Subtype Surveillance in Central Kenya S. Kageha, et al. Abstract Drug Resistance Pattern of HIV Type 1 Isolates Sampled in 2007 H. O. Ajoge, et al. Abstract from Therapy-Naive Pregnant Women in North-Central Nigeria Accumulation of HIV Drug Resistance Mutations in Patients Failing First-Line Antiretroviral Treatment in South Africa K. C. E. Sigaloff, et al. Abstract M. M. Santoro, et COMPARATIVE ANALYSIS OF al. DRUG-RESISTANCE AMONG B-AND THE MOST PREVALENT NON-B HIV-1 SUBTYPES (C, F AND CRF02_AG) IN ITALY Abstract Drug resistance mutations in the HIV-1 protease and reverse transcriptase genes in antiretroviral-naïve Vietnamese children Q. D. Trinh, et al. Abstract Drug resistance mutations of HIV-1 non-B viruses to integrase inhibitors in treatment-naïve patients from sub-Saharan countries and discordant interpretations M. Monleau, et al. Abstract Unusual insertion and deletion at codon 67 and 69 of HIV-1 subtype C reverse transcriptase among first-line HAART failing South Indian patients: association with other resistance mutations S. Saravanan, et al. Abstract High Prevalence of Transmitted Antiretroviral Drug Resistance Among Newly HIV Type 1 Diagnosed Adults in Mombasa, Kenya K. C. E. Sigaloff, et al. Abstract Recombination between Variants from Genital Tract and Plasma: Evolution of Multidrug-Resistant HIV-1 K. Kemal, et al. Abstract Phylodynamic and Phylogeographic Patterns of the HIV-1 Subtype F1 Parenteral Epidemic in Romania J. L. Mbisa, et al. Abstract Journal of Medical Virology The analysis of near full-length genome sequences of HIV-1 subtype A viruses from Russia supports the monophyly of major intrasubtype clusters A. FernándezGarcía, et al. Abstract HIV-1 Coreceptor Tropism, CCR5 Genotype and Integrase Inhibitor Resistance Profiles in Vietnam–Implications for the Introduction of New Antiretroviral Regimens Q. P. Luu, et al. Abstract No increase of drug-resistant HIV-1 prevalence among drugnaïve individuals in Northern Vietnam V. T. Tran, et al. Abstract Genetic Diversity and Naturally Polymorphisms in HIV-1 Integrase Isolates from Maputo, Mozambique: Implications for Integrase Inhibitors M. F. Oliveira, et al. Abstract C. K. Lee, et al. An in‐ house HIV genotyping assay for the detection of drug resistance mutations in Southeast Asian patients infected with HIV1 Abstract Prevalence of etravirine resistance associated mutations in HIV1 strains isolated from infected individuals failing efavirenz: Comparison between subtype B and non B genetic variants J. Pereira Vaz, et al. Minority HIV1 resistant variants in recent infection and in patients who failed first‐ line antiretroviral therapy with no detectable resistance associated mutations in Thailand H. Le Nguyen, et al. Abstract Characterization of drug resistance mutations in naïve and ART‐ treated patients infected with HIV‐ 1 in Yaounde, Cameroon L. Ceccarelli, et al. Abstract Abstract Tropical Medicine & International Health The role of sexually transmitted infections in the evolution of the South African HIV epidemic L. F. Johnson, et al. Abstract HIV medicine Predictive value of HIV‐ 1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment‐ experienced patients R. Bedimo, et al. Abstract C. Delaugerre, et Comparison of resistance al. mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replication Abstract Clinical Microbiology and Infection Evolution of transmitted HIV1 drug resistance in HIV1‐ infected patients in Italy since 2000 to 2010 M. Colafigli, et al. Abstract Biochemistry HIV-1 protease with 20 mutations J. Agniswamy, et al. exhibits extreme resistance to clinical inhibitors through coordinated structural rearrangements Abstract Science's STKE HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics That Are Corrected in the Presence of Drug O. Putcharoen, et al. Abstract Journal of the International AIDS Society Emergence of HIV-1 drug resistance mutations among antiretroviral-naive HIV-1infected patients after rapid scaling up of antiretroviral therapy in Thailand S. Sungkanuparph, et al. Abstract BMC Medical Research Methodology Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance H. Castro, et al. Abstract AIDS Research and Treatment Trends in Decline of Antiretroviral K. Buchacz, et al. Resistance among ARVExperienced Patients in the HIV Abstract Outpatient Study: 1999&# 8211; 2008 Impact of Novel Resistance Profiles in HIV-1 Reverse Transcriptase on Phenotypic Resistance to NVP L. Jiao, et al. Abstract Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India S. Sinha, et al. Abstract International journal of STD & AIDS Evaluation of HIV-1 resistance to antiretroviral drugs among 150 patients after six months of therapeutic interruption E. Kalmar, et al. Abstract The Lancet Infectious Diseases Dampening the effect of drug resistance in HIV: a leap forward J. D. Lundgren, et al. Abstract Scientific Reports Factors limiting the transmission of HIV mutations conferring drug resistance: fitness costs and genetic bottlenecks B. G. Wagner, et al. Abstract International Journal of Molecular Epidemiology and Genetics K. Diallo, et al. Comparison of HIV-1 resistance profiles in plasma RNA versus PBMC DNA in heavily treated patients in Honduras, a resourcelimited country Abstract Clinical Infectious Diseases Poorer Immunologic Outcome on Treatment Among Patients Infected with HIV-1 Non-B Subtypes Compared to Subtype B in Singapore L. K. Lee, et al. Abstract Antiviral Therapy HIV-1 drug resistance in antiretroviral-naive individuals with HIV-1-associated tuberculous meningitis initiating antiretroviral therapy in Vietnam V. P. Thao, et al. Abstract Retrovirology Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses C. S. Kraft, et al. Abstract Modulation of HIV-1 Gag NC/p1 N. M. van Abstract cleavage efficiency affects protease inhibitor resistance and viral replicative capacity Maarseveen, et al. Journal of Molecular Structure Multiple drug resistant mechanisms against darunavir, amprenavir, and nelfinavir of HIV-1 PR X. Liu, et al. Abstract Virology Ultra-Deep Sequencing of HIV-1 Reverse Transcriptase Before Start of an NNRTI-based Regimen in Treatment-naive Patients P. Messiaen, et al. Abstract Journal of Clinical Virology Automated sequence analysis and editing software for HIV drug resistance testing D. Struck, et al. Abstract HIV-1 subtypes D and F are prevalent in Guinea Conakry G. Freimanis, et al. Abstract Naturally occurring resistance mutations to HIV-1 entry inhibitors in subtypes B, C, and CRF31_BC L. A. L. Araújo, et al. Abstract Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes S. C. Aitken, et al. Abstract HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures K. C. Alcântara, et al. Abstract Infection, Genetics and Evolution Phylodynamics of HIV-1 subtype F1 in Angola, Brazil and Romania G. Bello, et al. Abstract Archives of Virology Impaired CD4+ cell recovery during antiretroviral therapy in patients with HIV resistance mutations K. W. Sühs, et al. Abstract Methods in molecular biology Decomposing the Energetic Impact of Drug-Resistant Mutations: The Example of HIV-1 Y. Cai, et al. Abstract Protease–DRV Binding